LivaNova PLC (LIVN)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

20 EASTBOURNE TERRACE LONDON, UNITED KINGDOM W2 6LG

LivaNova PLC operates as a medical technology company. The Company focuses on neuromodulation, cardiac surgery and cardiac rhythm management. LivaNova also develops medical solutions for the treatment of cardiovascular diseases.

Data as of 2020-09-12
Market Cap2.19 Billion Shares Outstanding48.667 Million Avg 30-day Volume492.028 Thousand
P/E Ratio Dividend Yield EPS-3.34
Price/Sales2.232 Price cash flow ratio65.5 Price free cash flow ratio-9.2
Book Value27.39 Price to Tangible Book-14.08 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.121741
BETA0.829342 52-week High/Low86.49 / 33.4 Stddev0.100092
View SEC Filings from LIVN instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 182 184 -1.09% 51 (3.33%) 46 (2.94%) 10.87%
13F shares: 45.361 Million 42.877 Million 5.79% 13.352 Million 10.899 Million 22.5%
% Ownership 93.2069 88.5066 5.31% 27.4346 22.4978 21.94%
New Positions: 33 26 26.92% 17 11 54.55%
Increased Positions 69 63 9.52% 16 17 -5.88%
Closed Positions 32 53 -39.62% 11 22 -50.0%
Reduced Positions 60 65 -7.69% 17 14 21.43%
Total Calls 21.42 Thousand 35.007 Thousand -38.81% 6.12 Thousand 10.9 Thousand -43.85%
Total Puts 8.103 Thousand 8 Thousand 1.29%
PUT/CALL Ratio 0.38 0.23 65.22% 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LIVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LIVN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

1.3 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SKEFFINGTON KEYNA PIDCOCK GENERAL COUNSEL

  • Officer
3,016 2020-09-15 6

HEBBELINCK TRUI CHIEF HUMAN RESOURCES OFFICER

  • Officer
454 2020-09-15 2

KHOURY ROY PRESIDENT, INTERNATIONAL

  • Officer
2,990 2020-08-05 6

BIANCHI FRANCESCO

  • Director
0 2020-06-29 2

MOORE DANIEL JEFFREY

  • Director
0 2020-06-29 3

NOVAK ALFRED J

  • Director
0 2020-06-29 3

MORRISON HUGH M

  • Director
0 2020-06-29 2

O'KANE SHARON

  • Director
0 2020-06-29 2

ROSENTHAL ARTHUR L

  • Director
0 2020-06-29 2

SAIA ANDREA LYNN

  • Director
0 2020-06-29 2

KOZY WILLIAM A

  • Director
0 2020-06-29 2

ENXING SENG STACY

  • Director
0 2020-06-29 2

HUSTON THAD ALLEN CHIEF FINANCIAL OFFICER

  • Officer
27,005 2020-05-23 5

MCDONALD DAMIEN CEO

  • Officer
75,840 2020-05-05 9

DOLCI MARCO SVP GLOBAL OPERATIONS, R&D

  • Officer
3,956 2020-05-05 5

MANKO DOUGLAS JOHN CHIEF ACCOUNTING OFFICER

  • Officer
3,277 2020-03-30 3

ANDRLE EDWARD GENERAL MANAGER, NM

  • Officer
0 2020-01-01 3

SIMPSON ALISTAIR GENERAL MANAGER, CS

  • Officer
0 2020-01-01 1

WISE DAVID S CHIEF ADMINISTRATIVE OFFICER

  • Officer
27,929 2019-01-15 0

GIANOTTI STEFANO

  • Director
No longer subject to file 2018-03-23 0

SEHGAL VIVID CFO

  • Officer
2,761 2017-03-11 0

BALLESTER ANDRE MICHEL CEO

  • Officer
No longer subject to file 2016-12-31 0

EQUINOX TWO S.C.A.

TOWER 6 S. A R.L.

  • 10% Owner
No longer subject to file 2016-09-21 0

GUTEDEL JACQUES PRESIDENT INTERCONTINENTAL

  • Officer
No longer subject to file 2016-08-09 0

DARNAUD MICHEL PRESIDENT CARDIAC SURGERY

  • Officer
No longer subject to file 2016-07-27 0

DI LULLO STEFANO PRES CARDIAC RHYTHM MGMT

  • Officer
No longer subject to file 2016-07-27 0

SHINMAR PRITPAL SR VP GLOBAL MARKET ACCESS

  • Officer
No longer subject to file 2016-07-27 0

VECCHI PIERO VP & CONTROLLER

  • Officer
No longer subject to file 2016-07-27 0

RICHEY ROBERT JASON PRESIDENT, NEUROMODULATION

  • Officer
No longer subject to file 2016-07-27 0

SHERIDAN BRIAN SR VP GENL COUNSEL & SECRETARY

  • Officer
0 2016-03-11 0

MAURO DEMETRIO CHIEF INTEGRATION OFFICER

  • Officer
No longer subject to file 2015-12-31 0

BIFULCO ROSARIO

  • Director
128,605 2015-10-19 0

HOARE ROHAN PRESIDENT, NEUROMODULATION

  • Officer
7,505 2015-10-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HEBBELINCK TRUI - Officer CHIEF HUMAN RESOURCES OFFICER

2020-09-17 11:07:09 -0400 2020-09-15 M 440 d 19,682 direct

SKEFFINGTON KEYNA PIDCOCK - Officer GENERAL COUNSEL

2020-09-17 11:12:27 -0400 2020-09-15 M 300 a 29,913 direct

HEBBELINCK TRUI - Officer CHIEF HUMAN RESOURCES OFFICER

2020-09-17 11:07:09 -0400 2020-09-15 F 207 $45.02 d 454 direct -1.433 -7.4295 0.0 1 -7.6058 5

SKEFFINGTON KEYNA PIDCOCK - Officer GENERAL COUNSEL

2020-09-17 11:12:27 -0400 2020-09-15 F 141 $45.02 d 3,016 direct -1.433 -7.4295 0.0 1 -7.6058 5

HEBBELINCK TRUI - Officer CHIEF HUMAN RESOURCES OFFICER

2020-09-17 11:07:09 -0400 2020-09-15 M 440 a 661 direct -1.433 -7.4295 0.0 1 -7.6058 5

SKEFFINGTON KEYNA PIDCOCK - Officer GENERAL COUNSEL

2020-09-17 11:12:27 -0400 2020-09-15 M 300 a 3,157 direct -1.433 -7.4295 0.0 1 -7.6058 5

KHOURY ROY - Officer PRESIDENT, INTERNATIONAL

2020-08-10 07:56:57 -0400 2020-08-05 M 573 a 3,260 direct -0.1457 0.8741 -11.5505 1.6025 3 -11.5505 31

KHOURY ROY - Officer PRESIDENT, INTERNATIONAL

2020-08-10 07:56:57 -0400 2020-08-05 M 573 d 36,471 direct

KHOURY ROY - Officer PRESIDENT, INTERNATIONAL

2020-08-10 07:56:57 -0400 2020-08-05 F 270 $47.38 d 2,990 direct -0.1457 0.8741 -11.5505 1.6025 3 -11.5505 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments